Horrible
The thing is that you only do one thing in the entire game: tap!!!! So there’s no point for the game.
Free
About
Engage in a microscopic battle within a patient's bloodstream. Your mission is to eliminate invading bacteria and viruses while carefully avoiding vital red and white blood cells. Manage the patient's infection rate and temperature to prevent critical organ damage and win the game.
✓Fight bacteria and viruses
✓Avoid red blood cells
✓Avoid white blood cells
✓Manage infection rate
✓Monitor patient temperature
✓Prevent brain cell death
Show original description
What's New in Nano Doc
1.1
July 16, 2019
Fixed an error that caused positive messages to not show up.
User reviews
Developer apps
FAQ
What is the objective of Nano Doc?
The objective of Nano Doc is to eliminate all bacteria and viruses in the patient's bloodstream, reducing the infection rate to 0% without causing critical damage to the patient's health.
How does Nano Doc handle ads?
Nano Doc is ad-free, allowing for uninterrupted gameplay without advertisements interrupting the experience.
What devices support Nano Doc?
Nano Doc is available on iPhone, iPad, and iPod devices, offering a consistent experience across Apple's mobile ecosystem.
What is the age rating for Nano Doc?
Nano Doc has an age rating of 9+, making it suitable for younger players and families.
How often is Nano Doc updated?
Nano Doc was last updated on July 16, 2019, with version 1.1. Further updates may be released based on developer plans.
What happens if I hit red blood cells in Nano Doc?
Hitting red blood cells in Nano Doc increases the patient's heart rate, making it more challenging to hit subsequent cells and manage the game.
What happens if I hit white blood cells in Nano Doc?
Hitting white blood cells in Nano Doc accelerates the rate at which viruses multiply, increasing the infection level and difficulty of the game.
What is the user sentiment for Nano Doc based on ratings?
Nano Doc has a rating of 3.7 stars from 3 ratings, indicating a generally positive but mixed reception from its limited user base.
